{"id":"W2741974392","doi":"10.1016/j.rmed.2017.07.062","title":"Therapeutic targets in idiopathic pulmonary fibrosis","year":2017,"lang":"en","type":"review","venue":"Respiratory Medicine","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Boehringer Ingelheim; Gilead Sciences; Canadian Pulmonary Fibrosis Foundation; GlaxoSmithKline","keywords":"Nintedanib; Medicine; Pirfenidone; Idiopathic pulmonary fibrosis; Clinical trial; Interstitial lung disease; Disease; Pulmonary fibrosis; Pathogenesis; Intensive care medicine; Lung; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001313598,0.001057143,0.00506561,0.0009905645,0.0002432464,0.00003604285,0.0007281053,0.000949416,0.0005235821],"category_scores_gemma":[0.000453432,0.0007549108,0.001068448,0.0004361515,0.000612661,0.000178657,0.0001931003,0.00155404,0.0003233066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005728381,"about_ca_system_score_gemma":0.001339929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007183385,"about_ca_topic_score_gemma":0.000007081707,"domain_scores_codex":[0.9948851,0.0004776523,0.001776758,0.001145045,0.000857164,0.0008582132],"domain_scores_gemma":[0.9962588,0.0001559402,0.00089096,0.001939536,0.0001524711,0.000602301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005221785,0.0002503186,0.00005217157,0.04536554,0.0002065942,0.003471418,0.00006507542,9.753363e-8,0.00002669572,0.0001361837,0.001484746,0.948419],"study_design_scores_gemma":[0.0007169701,0.00222908,0.0001395775,0.1367589,0.002002077,0.0003737253,0.00003245483,0.00001008246,8.832511e-7,0.00006153421,0.8571269,0.0005477676],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003244698,0.984564,0.00001224686,0.0002129313,0.001052322,0.001732613,0.00006695015,0.0001222831,0.01223339],"genre_scores_gemma":[0.001316693,0.9922708,0.00001213621,0.0007496359,0.0037534,0.0003265312,0.0002004409,0.0002109711,0.001159399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9478712,"threshold_uncertainty_score":0.9994902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1395791827068743,"score_gpt":0.4058700869435454,"score_spread":0.266290904236671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}